News
TELCOR is excited to share industry news and updates with our stakeholders across the country.
CMS Publishes Final Rule Streamlining Prior Authorization Process
On Jan. 17, the Centers for Medicare & Medicaid Services (CMS) announced the release of the CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F). The rule aims to optimize the [...]
New HIPAA Regulations Proposed for 2024 Related to Billing Records and Noncompliance Penalties
Several new Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule regulations have been proposed for 2024. According to an article published in The HIPAA Journal on Jan. 6, 2024, [...]
CMS and CDC Release Final Rule Updating CLIA Program
The Centers for Medicare & Medicaid Services and Centers for Disease Control and Prevention released a final rule on Dec. 28, 2023, updating the Clinical Laboratory Improvement Amendments of 1988 [...]
CMS Publishes Federal IDR Process Fact Sheet Explaining Fee Updates
The Centers for Medicare & Medicaid Services released a fact sheet on Dec. 18 explaining the finalized administrative and certified Independent Dispute Resolution (IDR) entity fees associated with the use [...]
HHS Finalized HTI-1 Rule for Health IT Interoperability and Algorithm Transparency
The U.S. Department of Health and Human Services through the Office of the National Coordinator for Health Information Technology (ONC) finalized its rule to advance health IT interoperability and algorithm [...]
Representatives Urge Leadership to Take Action on Medicare Payment Reductions; New Legislation Seeks to Prohibit Fees for Electronic Funds Transfers
Reps. Mariannette Miller Meeks, M.D. (R-Iowa), Ami Bera, M.D. (D-Calif.), Larry Bucshon, M.D. (R-Ind.), and Kim Schrier, M.D. (D-Wash.) are circulating a Nov. 16 letter addressed to House and Senate [...]
ACLA Comments on FDA Proposed Rule for Laboratory-Developed Tests
On Dec. 4, the American Clinical Laboratory Association (ACLA) submitted comments on the U.S. Food and Drug Administration proposed rule regarding laboratory-developed tests (LDTs). The ACLA expressed “grave concerns” with [...]
Continuing Resolution Signed Into Law Extends FY2024 Appropriations Deadlines
On Nov. 16, President Biden signed a continuing resolution (CR) into law that would continue fiscal year (FY) 2024 appropriations and extend funding for expiring programs. The CR sets two [...]
FDA Will Not Extend Comment Period for Laboratory-Developed Tests Proposed Rule
The U.S. Food and Drug Administration announced Oct. 30 that it will not extend the standard 60-day comment period for its proposed rule on laboratory-developed tests (LDTs). “After considering the [...]
Senate Finance Committee Passes Health Extenders Legislation
On Nov. 8, the Senate Finance Committee passed the Better Mental Health Care, Lower Drug Cost, and Extenders Act, which was reported out of committee 26 to 0. Among other [...]